NCT04075370View on ClinicalTrials.gov

Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Primary Brain TumorBrain Metastases, Adult
Interventions
OTHER

Neuropsychological Testing

Measure cognition function and cognitive reserve in patients before, during and after radiation therapy using cumulative scores of Hollingshead Index, North American Adult Reading Test, HVLT-R, TMT A\&B and COWA over time.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT04075370 - Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer | Biotech Hunter | Biotech Hunter